Because Oct4, Nanog and Sox2 were utilized for transfection of GBM cells, further elucidation of their role in the regulation of these pathways may help us understand CSC physiology and develop potential therapeutic interventions aimed at differentiating tumour cells to render them more sensitive to chemotherapy or other standard agents. This evidence concerns the gene SOX2 and neoplasm.